Dasatinib
Dasatinib induces hematologic and cytogenetic responses in patients with CML or Ph-positive ALL who cannot tolerate or are resistant to imatinib.[1]
This is an old revision of this page, as edited by Copper0722~enwiki (talk | contribs) at 10:41, 22 July 2006. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Dasatinib induces hematologic and cytogenetic responses in patients with CML or Ph-positive ALL who cannot tolerate or are resistant to imatinib.[1]